VisMederi Holding
Improving human healthVisMederi Holding
VisMederi Holding is the company that holds a qualified share of the companies that are part of the VisMederi Group. The Group of VisMederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.
Revenues
Employees
Global Partnerships
Vismederi Holding: latest news
All the news of the group
Bundibugyo ebolavirus: supporting vaccine development for an emerging public health threat
VisMederi Expands Its Service Portfolio with End-to-End Sample Kit Management
VisMederi and CEVAC Sign Memorandum of Understanding to Strengthen Vaccine Clinical Trial Capabilities in Europe
VisMederi and KingMylab Sign Strategic Partnership to Strengthen Global Clinical Trial Testing Services for Vaccines and Biologics
VisMederi signs vaccine research partnership with GCCL at World Vaccine Congress 2026
Universal influenza vaccine candidate, collaboration with Sumitomo Pharma Co., Ltd. and Japan’s National Institutes of Biomedical Innovation Health and Nutrition (NIBN)
VisMederi is a partner in the EU-selected NOFLU consortium supporting early clinical development of a next-generation pandemic influenza vaccine
VisMederi steps up Nipah readiness as India reports a new signal in West Bengal.
VisMederi drives progress toward the 100 Days Mission through CEPI’s world-leading network
New scientific publication: “High-dose influenza vaccine: enhanced protection for the elderly”
Where we
are
The
founder
Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.